Hypofractionated Stereotactic Irradiation (HFSRT) With Pembrolizumab and Bevacizumab for Recurrent High Grade Gliomas
Clinical trial NCT02313272 · COMPLETED
Trial details
- NCT number
- NCT02313272
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-28
- Primary completion
- 2018-09-13
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.